New York, NY -- (ReleaseWire) -- 03/18/2013 --New York Mortgage Trust Inc. (NASDAQ: NYMT) recently reported results for the three and twelve months ended December 31, 2012.
Net income attributable to common stockholders of $9.4 million for the quarter ended December 31, 2012, representing net income per weighted average share of $0.19, and net income attributable to common stockholders of $28.3 million for the year ended December 31, 2012, representing net income per weighted average share of $1.08.
Declared fourth quarter dividend of $0.27 per common share that was paid on January 25, 2013.
NYMT is an internally managed real estate investment trust, or REIT, which invests in mortgage-related and financial assets.
Get the latest trend analysis reports on NYMT here:
http://www.wallstreetscoop.net/market-scan/?symbol=NYMT
ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) is a biopharmaceutical company focused on the discovery and development of new cancer therapies.
Programs developed by the U.S. Food and Drug Administration to speed up the approval process has been a major driver for growth within the Biotech Industry. In 2012, FDA drug approvals totaled a 15-year high of 39, over the past decade drug approvals has averaged roughly 23 a year, according to a recent Bloomberg article.
The company's portfolio is comprised of five clinical-stage product candidates in all phases of development, as well as multiple research-stage candidates. ZIOPHARM has recently intitiated a Phase 2 clinical study of Ad-RTS IL-12 in combination with palifosfamide for the treatment of advanced breast cancer.
Find out where ZIOP could be headed here:
http://www.wallstreetscoop.net/market-scan/?symbol=ZIOP
About WallStreetScoop.net
WallStreetScoop.net issues momentum alerts on stocks that can provide gains to day traders and short-term investors. WallStreetScoop.net provides members with timely information and exclusive alerts on under-valued stocks in the United States with the potential to deliver short-term gains.
WallStreetScoop.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetScoop.net is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading small cap stocks. Gain an Edge by joining the WallStreetScoop.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Scoop believes traders should have a chance at successfully trading Small stocks and invites traders and investors to be part of the free membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.WallStreetScoop.net
Disclosure
WallStreetScoop.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetScoop.Net website, for complete risks and disclosures.
Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.
For full disclaimer visit: http://www.wallstreetscoop.net/disclaimer/
Contact Info:
Thomas Greene
Wall Street Scoop
info@wallstreetscoop.net
347-905-5009